← SynDRA
SULFAMETER
SynDRA canonical compound SYN0022938 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | DHFR |
|---|
| Mechanism of action | dihydrofolate reductase inhibitor |
|---|
| Indication | urinary tract infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- dihydrofolate reductase inhibitor
- folP INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- GMNN
- HDAC6
- LMNA
- PTH1R
- SAMHD1
- SLCO1B3
- SMAD3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Anti-Infective Agents, Urinary
- Leprostatic Agents
ATC classes
- J01E · SULFONAMIDES AND TRIMETHOPRIM
Cross-references
Synonyms
- SULLA
- sulfamethoxydiazine
- methoxypyrimal
- sulfamethoxine
- sulfamethoxydin
- sulfamethoxypyrimidine
- sulfametin
- sulfametorine
- sulfametoxydiazine
- sulphamethoxydiazine
- Sulfametoxydiazine
- Sulfametoxidiazina
- Sulfamethoxydiazine
- Sulfamethoxypyrimidine
- Sulfametin
- Sulphamethoxydiazine
- Ultrax
- AHR-857
- BAY-5400
- NSC-683528
- NSC-757874
- SH-613
- Bayrena
- Sulla
- Sulfamethoxine
- Sulphameter
- Sulfa-5-methoxypyrimidine
- Solfametossidiazina
- Sulfametoxydiazinum
- 2-Sulfanilamido-5-methoxypyrimidine
- 5-Methoxy-2-sulfanilamidopyrimidine
- 2-Sulfanilamido-5-methoxypyrimidin
- 2-(4-Aminobenzenesulfonamido)-5-methoxypyrimidine
- N(sup 1)-(5-Methoxy-2-pyrimidinyl)sulfanilamide
- NSC 683528
- CHEBI:53727
- SH 613
- 3L179F09D6
Look up SULFAMETER in the interactive SynDRA portal →